Indusatumab

• Description :

  Indusatumab (5F9 Monoclonal antibody) is a monoclonal antibody against human GUCY2C (Guanylate cyclase 2C) . Indusatumab can be used to synthesize ADCs, such as Indusatumab vedotin (HY-P99662) . Indusatumab can be used in cancer research[1].

• Product Name Alternative :

  5F9 Monoclonal antibody

• UNSPSC :

  12352203

• Target :

  Guanylate Cyclase

• Type :

  Inhibitory Antibodies

• Related Pathways :

  GPCR/G Protein

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/indusatumab.html

• Purity :

  99.0

• Solubility :

  10 mM in DMSO

• Smiles :

  [Indusatumab]

• Molecular Weight :

  (145.206 kDa)

• References & Citations :

  [1]e Goeij BE, et al. New developments for antibody-drug conjugate-based therapeutic approaches. Curr Opin Immunol. 2016 Jun;40:14-23.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported

• CAS Number :

  [1497400-26-6]